This company can be accessed online by simply using their name as a search keyword. Clicking on this will take you to their website. Then enter the keywords inhalation and antibiotic and you will find a projected market report for inhaled antibiotics through 2015. This post was taken down yesterday by those who would want potential investors to believe the market for new inhalation antibiotics is $billions. It is not. Those interested in facts should do their own DD.
The company subsidized cost for monthly doses of any of the inhalational antibiotics is around $4,000 plus. Insurance covered costs are much less. The non-subsidized cost is over $6,000 per month. Those costs include TOBI, Cayston and probably the others. Getting actual cost information online is problematical because of competition from distributors. They want to get the hook into the patient and then talk them to the "let's make a deal price" of $4,500. If you go to a retail pharmacy with no insurance, TOBI can cost as much as $7,200 per month. Staggering, but the off (non-treatment period) makes the average annual number of treatment periods per patient much lower.
analysts forecast the Global Inhaled Antibiotics market to reach US$875 million by 2015. One of the key ... The Global Inhaled Antibiotics market has also been witnessing the trend of huge investment in R&D of drugs by the vendors. However, the high cost of inhaled antibiotics could pose a challenge to the growth Uh Oh Fud!..you have been very misleading.